These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1475268)

  • 1. [The effect of flupirtine on respiratory drive in healthy probands and patients with various lung diseases].
    Magnussen H; Scheidt-Mackes M
    Pneumologie; 1992 Nov; 46(11):580-6. PubMed ID: 1475268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of theophylline in chronic obstructive lung disease.
    Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of respiratory function (respiratory function tests)].
    Orehek J
    Rev Mal Respir; 1998 Sep; 15 Suppl 2():S29-32. PubMed ID: 9809340
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative study of the effects of zopiclone and placebo on respiratory function in patients with chronic obstructive respiratory insufficiency.
    Muir JF; DeFouilloy C; Broussier P; Locquet R; Maillard F
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():85-94. PubMed ID: 2201733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffference between mouth and esophageal occlusion pressure during CO2 rebreathing in chronic obstructive pulmonary disease.
    Marazzini L; Cavestri R; Gori D; Gatti L; Longhini E
    Am Rev Respir Dis; 1978 Dec; 118(6):1027-33. PubMed ID: 369409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of theophylline on ventilatory regulation in patients with chronic obstructive pulmonary disease].
    Ikeda A; Senju S; Toyoshima H; Miyahara S; Aritomi T; Watanabe K; Ishibashi M; Yoshida M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Nov; 31(11):1441-8. PubMed ID: 8277616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations with the novel non-opioid analgesic flupirtine in regard to possible benzodiazepine-like abuse inducing potential.
    Nickel B; Borbe HO; Szelenyi I
    Arzneimittelforschung; 1990 Aug; 40(8):905-8. PubMed ID: 1978681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of limited mouth opening capacity (trismus) on lung function].
    Krennmair G; Mayer K; Roithinger FX; Pachinger O
    Wien Klin Wochenschr; 1998 Apr; 110(8):292-5. PubMed ID: 9615961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The analgesic efficacy of flupirtine in comparison to pentazocine and placebo assessed by EEG and subjective pain ratings.
    Bromm B; Ganzel R; Herrmann WM; Meier W; Scharein E
    Postgrad Med J; 1987; 63 Suppl 3():109-12. PubMed ID: 2451815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Does halothane, in subnarcotic dosage, have a detectable broncholytic effect?].
    Gerking A; Ebert C; Precht B; Paliege R; Kirsten D; Pielesch W
    Z Erkr Atmungsorgane; 1986; 166(2):180-5. PubMed ID: 3716494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intracerebrally injected aminophylline, vinpocetinum, vasoactive intestinal peptide and onion extract on breathing pattern of rats.
    Vertes C; Debreczeni LA
    Z Erkr Atmungsorgane; 1989; 173(2):134-7. PubMed ID: 2588686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Functional and diagnostic significance of a study of respiratory regulation in patients with chronic nonspecific lung diseases].
    Breslav IS; Klement RF; Kochubeev AV
    Ter Arkh; 1987; 59(12):44-8. PubMed ID: 3447289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia.
    Klein T; Magerl W; Hanschmann A; Althaus M; Treede RD
    Eur J Pain; 2008 Jan; 12(1):17-29. PubMed ID: 17449306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume acceleration as an index of respiratory drive during exercise.
    Uruma T; Kimura H; Kojima A; Hasako K; Masuyama S; Tatsumi K; Kuriyama T
    Clin Sci (Lond); 2000 Jan; 98(1):91-101. PubMed ID: 10600663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oxygen on breathing during exercise in patients with chronic obstructive lung disease.
    Scano G; van Meerhaeghe A; Willeput R; Vachaudez JP; Sergysels R
    Eur J Respir Dis; 1982 Jan; 63(1):23-30. PubMed ID: 6802664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of functional NMDA-antagonist flupirtine on automatic postural responses in Parkinson's disease.
    Putzki N; Maschke M; Drepper J; Diener HC; Timmann D
    J Neurol; 2002 Jul; 249(7):824-8. PubMed ID: 12140664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory center output following zopiclone or diazepam administration in patients with pulmonary disease.
    Beaupré A; Soucy R; Phillips R; Bourgouin J
    Respiration; 1988; 54(4):235-40. PubMed ID: 3249838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with flupirtine in the U.S.
    McMahon FG; Arndt WF; Newton JJ; Montgomery PA; Perhach JL
    Postgrad Med J; 1987; 63 Suppl 3():81-5. PubMed ID: 3328854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of the analgesic flupirtine on automobile driving].
    Biehl B
    Arzneimittelforschung; 1985; 35(1):77-81. PubMed ID: 4039155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of halothane, enflurane and isoflurane on resistance and compliance in patients with asthma or chronic obstructive lung diseases].
    Pasch T; Kamp HD; Petermann H
    Anaesthesist; 1991 Feb; 40(2):65-71. PubMed ID: 2048706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.